Bernanke bump: Stocks tend to rally on testimony Stocks

New Post Public Reply Private Reply Replies (0) Message Board
ruliquid

Bernanke bump: Stocks tend to rally on testimony
Stocks have received average 0.5% boost after testimony recently

SAN FRANCISCO (MarketWatch) — Expect stocks to finish higher after Federal Reserve Chairman Ben Bernanke gives his semiannual testimony to Congress on Tuesday and Wednesday, if history serves as any guide. http://www.marketwatch.com/story/bernanke-bum...2013-02-24

Over the past six years, the S&P 500 Index (SNC:SPX)  has finished higher nine out of 12 times during the two-day period over which the Fed chair has answered questions from Congress. By the close of the second day’s testimony, from the close before the first day, the stock index has gained an average 0.5%, a MarketWatch analysis of FactSet data shows.

S&P 500 before and after
S&P 500 during Bernanke’s semiannual
monetary policy report to Congress
testimony dates 2 day S&p 500 change S&P close before s&P close after
Feb 14-15, 2007 +0.87% 1,444.26 1,456.81
July 18-19, 2007 +0.24% 1,549.37 1,553.08
Feb 27-28, 2008 -0.99% 1,381.29 1,367.68
July 15-16, 2008 +1.39% 1,228.3 1,245.36
Feb 24-25, 2009 +2.94% 743.33 764.9
July 21-22, 2009 +0.30% 951.13 954.07
Feb 24-25, 2010 +0.76% 1,094.6 1,102.94
July 21-22,
2010
+0.94% 1,083.48 1,093.67
March 1-2, 2011 -1.42% 1,327.22 1,308.44
July 13-14, 2011 -0.36% 1,313.64 1,308.87
Feb 29-March 1, 2012 +0.14% 1,372.18 1,374.09
July 17-18, 2012 +1.41% 1,353.64 1,372.78

Source: FactSet

Since 2007, the biggest bump to markets during Bernanke’s testimony was Feb. 24-25, 2009, when the S&P 500 rose nearly 3% over the course of the two-day meeting. Then again, the index was dragging its knuckles in the 700s at the time, compared to more than 1500-level as of Friday’s close. The Fed had just cut interest rates to their current near-zero levels that past December, and the first round of quantitative easing measures had started in November.

The biggest two-day drop, 1.4%, came after the March 1-2, 2011, talk, after Bernanke warned that a violation of the country’s debt ceiling would likely create a new financial crisis and House Republicans criticized QE2.

On Tuesday and Wednesday, Bernanke will have to bridge divisions within the Fed in his testimony before Congress. Infighting between hawks and doves spilled out in Federal Open Market Committee meeting released this past Wednesday. That helped drive the S&P 500 down nearly 2% over two days.

That pull on the S&P 500 contributed to the index’s first losing week of 2013 with a 0.3% decline. The Nasdaq Composite Index (NASDAQ:COMP)  also had its worst week of the year, closing down 1%.

For some strategists, that sort of divisiveness is not likely to deter Bernanke from maintaining the present course of easing measures.

“Over the last couple of years, public division in the Fed has leaked outside, and that leads people to assume certain things,” said Dan Greenhaus, chief global strategist at BTIG. With that in mind, it’s up to the Fed Chairman to bridge the gap.

“Bernanke’s testimony is helpful in centering market participants’ expectations,” he said.

While division within the Fed may go deeper, and be more public than before, Greenhaus said the core of the Fed — Bernanke, Vice Chair Janet Yellen, and New York Fed President William Dudley — still favors additional easing and Bernanke’s likely to repeat that.

On the other hand, markets may be better served if the Fed signals a willingness to pursue a less aggressive monetary policy, said Brian Belski, chief investment strategist at BMO Capital Markets.

A scaling back of QE measures and higher interest rates, however, may be troublesome for the market in the short-term as investor culture has become firmly rooted in a reactionary “fire-aim-ready” mindset, he said.

“We in the world of investing have now reared an entire generation of investors that firmly believe that stocks need monetary policy to go up,” said Belski.

More aggressive Fed actions have certainly gone hand in hand with a massive rebound in stocks.

The Federal Reserve first announced what would come to be known as the first round of extraordinary stimulus measures, or quantitative easing, on Nov. 25, 2008. Following those bond-buying measures, plus the subsequent QE2 and QE3 programs and measures like Operation Twist, the S&P 500 has risen nearly 664 points, or 78%, to Friday’s close of 1,515.60. In comparison, the S&P 500 had fallen 713 points, or about 46%, from its high of 1,565.15 on Oct. 9, 2007, until the first announcement of QE.

While Belski expects Bernanke to not say anything definitive to Congress, he does expect he will signal it’s okay to take the foot off the monetary policy accelerator because the economy is in better shape and that rising interest rates will be a good thing.

“The fundamental approach is interest rates will ultimately go up because of stability and strength of the economy,” he said. “When the economy goes up, it’ll be good for stock prices. Rising interest rates can be a good thing, and not a cycle buster, and stocks will benefit from them.”

In his testimony before Congress, Bernanke needs “to be very simple and clear because he doesn’t want to create an overreaction [in markets].”

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 288

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 327

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 102

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 238

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 210

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 230

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 138

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 140

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 263

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 175

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Offering: Capital Southwest's $350 Million Bond Deal

Updated Category News Views 209

Capital Southwest Corporation's Noteworthy Bond Offering Capital Southwest Corporation (NASDAQ: CSWC) has made headlines with its recent pricing of a public offering, amounting to a significant $350 million in 5.950% notes due in 2030. This strategic financial move showcases the Company’s commitment to expanding its investment capabilities while ensuring a stable...

Continue Reading
Nektar Therapeutics Enhances CAR-T Efficacy with NKTR-255

Updated Category News Views 392

Nektar Therapeutics Elevates CAR-T Therapy with NKTR-255 Nektar Therapeutics (Nasdaq: NKTR) has recently showcased remarkable findings from its Phase 2 clinical trial, emphasizing the efficacy of its investigational treatment NKTR-255. This new therapy aims to enhance the effectiveness of CD19-directed CAR-T cell therapy in patients suffering from relapsed or refractory...

Continue Reading
Motorcycle Accessories Market Expected to Hit $33.85 Billion

Updated Category News Views 132

Growth Potential in the Motorcycle Accessories Market The motorcycle accessories market is set for substantial growth, showing a remarkable increase from USD 21.18 billion in 2025 to an estimated USD 33.85 billion by 2034. This surge indicates a Compound Annual Growth Rate (CAGR) of 5.35%. Such an escalation in market size reflects broader trends in consumer behavior and...

Continue Reading
Dealerlogix Joins GM's 3Synergy Program to Enhance Services

Updated Category News Views 584

Dealerlogix Enters GM’s 3Synergy Program Dealerlogix, powered by Vehlo, has successfully joined General Motors' 3Synergy service lane tool program. This innovative fixed operations platform offers GM dealers a robust, all-in-one solution designed to enhance service department efficiency. With a range of customizable features, Dealerlogix aims to automate vital...

Continue Reading
Growth of PD-(L)1 Inhibitors in Oncology Highlighted by Trends

Updated Category News Views 140

Emerging Trends in the PD-(L)1 Inhibitors Market As innovations in immunotherapy continue to shape cancer treatment, the PD-(L)1 inhibitors market is witnessing significant growth. These therapies are redefining patient outcomes across various cancers, prompting both researchers and pharmaceutical companies to invest heavily in this evolving space. Understanding PD-(L)1...

Continue Reading